Identifying and Verifying AR, ERBB2, and VEGFA Are the Targets of Qigesan in the Treatment of Esophageal Adenocarcinoma In Silico and In Vitro
- Type
- Retraction
- Notice date
- 8/9/2023 0:00
- Journal
- Scientific Programming
- Publisher
- Hindawi
- Notice DOI
- 10.1155/2023/9832042
- Original paper DOI
- 10.1155/2021/5463724
Reasons
- Concerns/Issues about Data
- Concerns/Issues about Results and/or Conclusions
- Concerns/Issues about Referencing/Attributions
- Concerns/Issues about Peer Review
- Investigation by Journal/Publisher
- Investigation by Third Party
- Paper Mill
- Computer-Aided Content or Computer-Generated Content
- Unreliable Results and/or Conclusions